References
  1. Kalarus Z, Svendsen JH, Capodanno D, et al. Cardiac arrhythmias in the emergency settings of acute coronary syndrome and revascularization: an European Heart Rhytm Association (EHRA) consensus document, endorsed by the European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Acute Cardiovascular Care Association (ACCA). Europace. 2019;21:1603-1604.
  2. Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J . 2018;39:119-177.
  3. Kober L, Swedberg K, McMurray JJ, et al. Previously known and newly diagnosed atrial fibrillation: a major risk indicator after a myocardial infarction complicated by heart failure or left ventricular dysfunction. Eur J Heart Fail. 2006;8:591-598.
  4. Türk UÖ, Zoghi M, Alioğlu E, Ergene O. Rationale and design of the myocardial infarction with non-obstructive coronary arteries in Turkish population (MINOCA-TR) study. Turk Kardiyol Dern Ars . 2019;47:662-668.
  5. Yasuda S, Kaikita K, Akao M, et al; AFIRE Investigators. Antithrombotic therapy for atrial fibrillation with stable coronary disease. N Engl J Med. 2019;381:1103-1113.
  6. Banach M, Rysz J, Drozdz JA, et al. Risk factors of atrial fibrillation following coronary artery bypass grafting: A preliminary report. Circ J. 2006;70:438-441.
  7. Rathore SS, Berger AK, Weinfurt KP, et al. Acute myocardial infarction complicated by atrial fibrillation in the elderly: prevalence and outcomes. Circulation. 2000;101:969-974.
  8. Yavuz B, Ata N, Oto E, et al. Demographics, treatment and outcomes of atrial fibrillation in a developing country: the population-based TuRkish Atrial Fibrillation (TRAF) cohort. Europace.2017;19:734-740.
  9. Ertaş FS, Tokgözoğlu L; EPICOR Study Group. Pre- and in-hospital antithrombotic management patterns and in-hospital outcomes in patients with acute coronary syndrome: data from the Turkish arm of the EPICOR study. Anatol J Cardiol. 2016;16:900-915.
  10. Awad HH, Zubaid M, Alsheikh-Ali AA, et al. Comparison of characteristics, management practices, and outcomes of patients between the global registry and the gulf registry of acute coronary events. Am J Cardiol. 2011;108:1252-1258.
  11. Mohamed MO, Kirchhof P, Vidovich M, et al. Effect of concomitant atrial fibrillation on in-hospital outcomes of non-ST-elevation acute coronary syndrome-related hospitalizations in the United States.Am J Cardiol. 2019;124:465-475.
  12. Mehta LS, Beckie TM, DeVon HA, et al. Acute myocardial infarction in women: a scientific statement from the American Heart Association.Circulation. 2016;133:916-947.
  13. Kilic D, Ozturk S. Gender differences in cigarette consumption in Turkey: evidence from the Global Adult Tobacco Survey. Health Policy. 2014;114:207-214.
  14. Kallistratos MS, Poulimenos LE, Manolis AJ. Atrial fibrillation and arterial hypertension. Pharmacol Res. 2018;128:322-326.
  15. Namana V, Gupta SS, Sabharwal N, Hollander G. Clinical significance of atrial kick. QJM. 2018;111:569-570.
  16. Saito Y, Kobayashi Y. Triple therapy: A review of antithrombotic treatment for patients with atrial fibrillation undergoing percutaneous coronary intervention. J Cardiol. 2019;73:1-6.
  17. Lopes RD, Hong H, Harskamp RE, et al. Optimal antithrombotic regimens for patients with atrial fibrillation undergoing percutaneous coronary intervention: an updated network meta-analysis. JAMA Cardiol.2020;5:1-8.
  18. January CT, Wann LS, Calkins H, et al. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: A report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society in collaboration with the Society of Thoracic Surgeons. Circulation. 2019;140:e125-e151.
  19. Steffel J, Verhamme P, Potpara TS, et al; ESC Scientific Document Group. The 2018 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Eur Heart J. 2018;39:1330-1393.
Table-1: Demographic and clinical characteristics of study population at admission.